Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?
Nephrology @ Point of Care · 2017
DOI: 10.5301/napoc.5000210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology @ Point of Care, 2017. Verfasst von Sara Dominijanni und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Diabetic nephropathy is one of the most frequent microvascular complications in diabetic patients. This report describes a case of diabetic nephropathy in an male adult (diabetic) patient treated with standard therapy and the contribution of the new antidiabetic drugs on the progression of the disease. We will deal the following questions: 1. What do we know about diabetic nephropathy and its natural history? 2. How should we manage diabetic nephropathy and what do the guidelines suggest on hyperglycemia? 3. How do we manage hyperglycemia in diabetic patients with chronic kidney disease (CKD)? Standard treatment. 4. What's news about antidiabetic medication? New treatment. 5. What's next?
Zitieren
APA
Dominijanni, S., Cipriani, S., Malaguti, M., Triolo, L., Ansali, F., & Floccari, F. (2017). Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?. Nephrology @ Point of Care. https://doi.org/10.5301/napoc.5000210
Vancouver
Dominijanni S, Cipriani S, Malaguti M, Triolo L, Ansali F, Floccari F. Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?. Nephrology @ Point of Care. 2017. doi:10.5301/napoc.5000210
BibTeX
@article{Dominijanni2017,
author = {Dominijanni, Sara and Cipriani, Silvia and Malaguti, Moreno and Triolo, Luigi and Ansali, Ferruccio and Floccari, Fulvio},
title = {Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?},
journal = {Nephrology @ Point of Care},
year = {2017},
doi = {10.5301/napoc.5000210}
}
EUVIMED